SCHEMBL2299719

SCHEMBL2299719

CC(C)(C)C1CCC(OOC(=O)OC2CCC(C(C)(C)C)CC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
APOBEC3A P31941 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
HTT P42858 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP19A1 P11511 1/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
GAA P10253 1/20 0.40
EPHX1 P07099 1/20 0.36
LIPA P38571 1/20 0.34
CYP2D6 P10635 1/20 0.33
KCNH2 Q12809 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
GLA P06280 1/20 0.32
EPHX2 P34913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL975283 0.91 MAPT (0.43) MAPTAPOBEC3AAPOBEC3GHTTSMN1; SMN2
SCHEMBL22733770 0.90 MAPT (0.42) MAPTAPOBEC3AAPOBEC3GHTTSMN1; SMN2
SCHEMBL35809 0.90 MAPT (0.50) MAPTAPOBEC3AAPOBEC3GHTTSMN1; SMN2
SCHEMBL1125849 0.90 MAPT (0.42) MAPTAPOBEC3AAPOBEC3GHTTSMN1; SMN2
SCHEMBL1820747 0.87 MAPT (0.47) MAPTAPOBEC3AAPOBEC3GHTTSMN1; SMN2
SCHEMBL22733771 0.86 MAPT (0.53) MAPTAPOBEC3AAPOBEC3GHTTSMN1; SMN2
SCHEMBL5759240 0.84 MAPT (0.45) MAPTAPOBEC3AAPOBEC3GHTTSMN1; SMN2
SCHEMBL4652918 0.84 MAPT (0.45) MAPTAPOBEC3AAPOBEC3GHTTSMN1; SMN2
SCHEMBL321173 0.84 MAPT (0.45) MAPTAPOBEC3AAPOBEC3GHTTSMN1; SMN2
SCHEMBL19594667 0.84 MAPT (0.45) MAPTAPOBEC3AAPOBEC3GHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353967-A1 CURABLE SILOXANE RESIN COMPOSITION AND FILM INCLUDING THE SAME KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2025-11-20 US claimed
US-12421170-B2 Granulate material and associated coating that is low in odor and emissions, particularly a construction element coating, for example a floor coating, based on a radical polymerization SIDEC NV (BE) 2025-09-23 US claimed
US-12331164-B2 Curable siloxane resin composition KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2025-06-17 US claimed
US-20220220031-A1 GRANULATE MATERIAL AND ASSOCIATED COATING THAT IS LOW IN ODOR AND EMISSIONS, PARTICULARLY A CONSTRUCTION ELEMENT COATING, FOR EXAMPLE A FLOOR COATING, BASED ON A RADICAL POLYMERIZATION SIDEC NV (BE) 2022-07-14 US claimed
EP-3805301-A1 STORAGE-STABLE CURING COMPOSITION FOR A REACTION RESIN Hilti Aktiengesellschaft (LI) 2021-04-14 EP claimed
EP-3380552-B1 BCHPC HAVING A REDUCED BURNING RATE UNITED INITIATORS GMBH (DE) 2019-11-13 EP claimed
EP-3380552-A1 BCHPC HAVING A REDUCED BURNING RATE United Initiators GmbH (DE) 2018-10-03 EP claimed
WO-2017089375-A1 BCHPC HAVING A REDUCED BURNING RATE UNITED INITIATORS GMBH (DE) 2017-06-01 WO claimed
US-20090203816-A1 Polypropylene resin composition BASELL POLIOLEFINE ITALIA S.R.I. (IT) 2009-08-13 US claimed
US-6989424-B2 Curing agent component for an at least two-component mortar composition, method of preparing it and its use HILTI AKTIENGESELLSCHAFT (LI) 2006-01-24 US claimed
EP-1371671-B1 Curing agents for a mortar composition comprising at least two components, process for their production and their use HILTI AG (LI) 2005-10-26 EP claimed
US-20030232909-A1 Curing agent component for an at least two-component mortar composition, method of preparing it and its use HILTI AKTIENGESELLSCHAFT (LI) 2003-12-18 US claimed
EP-1371671-A1 Curing agents for a mortar composition comprising at least two components, process for their production and their use HILTI Aktiengesellschaft (LI) 2003-12-17 EP claimed
EP-0034086-B1 PROCESS FOR THE SYNTHESIS OF POLYMERS AND COPOLYMERS BASED ON VINYLCHLOROFORMIATE SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1983-07-20 EP claimed
US-4381385-A Process for the preparation of polymers and copolymers based on vinyl chloroformate SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1983-04-26 US claimed
US-4046850-A Continuous casting of a polymerizable composition between moving endless belts SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-09-06 US claimed
CN-116535839-B Resin composition and product thereof 台光电子材料(昆山)股份有限公司 2026-05-19 CN disclosed
US-12552974-B2 Method of disposing an adhesive onto a substrate and article 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-02-17 US disclosed
US-4046850-A Continuous casting of a polymerizable composition between moving endless belts SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-09-06 US disclosed
US-3994849-A DIMENSIONAL STABILITY, DIELECTRICS SCM (CANADA) LIMITED (CA) 1976-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552974-B2 Method of disposing an adhesive onto a substrate and article ITGB2, ITGB3, ITGB1 MAPT 2614/4885APOBEC3A 952/4885APOBEC3G 1764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.